| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 376.81M | 366.61M | 366.51M | 408.37M | 385.37M | 250.16M |
| Gross Profit | 63.05M | 61.45M | 62.10M | 78.50M | 90.00M | 43.62M |
| EBITDA | 29.79M | 30.11M | 34.73M | 48.94M | 62.30M | 22.84M |
| Net Income | 17.65M | 18.15M | 22.66M | 35.92M | 45.64M | 14.98M |
Balance Sheet | ||||||
| Total Assets | 278.63M | 275.45M | 269.70M | 250.36M | 224.81M | 167.99M |
| Cash, Cash Equivalents and Short-Term Investments | 59.84M | 69.12M | 75.88M | 62.61M | 37.03M | 28.62M |
| Total Debt | 8.62M | 12.02M | 8.67M | 6.60M | 5.00M | 4.85M |
| Total Liabilities | 53.42M | 54.97M | 54.47M | 54.78M | 60.84M | 48.91M |
| Stockholders Equity | 225.21M | 220.48M | 215.23M | 195.57M | 163.97M | 119.08M |
Cash Flow | ||||||
| Free Cash Flow | 906.00K | 3.56M | 17.98M | 33.83M | 16.38M | 16.18M |
| Operating Cash Flow | 19.10M | 17.02M | 23.57M | 37.13M | 20.69M | 18.14M |
| Investing Cash Flow | -17.95M | -9.80M | -1.97M | -3.23M | -6.50M | -1.96M |
| Financing Cash Flow | -8.77M | -17.61M | -8.33M | -8.32M | -5.79M | -4.51M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £1.17B | 5.07 | 7.90% | 4.47% | 7.83% | -7.40% | |
74 Outperform | £1.44B | 12.13 | 6.07% | ― | 32.27% | ― | |
69 Neutral | £345.41M | 14.49 | 6.91% | 2.13% | 15.99% | 96.05% | |
68 Neutral | £366.45M | 38.43 | 2.91% | 4.18% | 1.31% | 10.19% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | £213.82M | 5.50 | 8.10% | 3.62% | 4.03% | -13.76% | |
48 Neutral | £412.08M | 179.13 | 3.10% | 2.39% | 5.58% | 66.49% |
James Latham has disclosed that the trustees of its Employee Benefits Trust have purchased 10,000 ordinary shares in the company at an average price of 1080.5p per share, with 6,347 shares now held by the trust, representing 0.03% of total voting rights. The shares are intended to support the firm’s share incentive and SIP schemes for employees, and further market purchases may be made at the independent trustee’s discretion to satisfy future awards, underscoring the company’s ongoing use of equity-based remuneration to incentivise staff and potentially directors.
The EBT’s role is to hold ordinary shares for the benefit of James Latham employees and to satisfy the vesting of awards under its incentive plans, which can enhance retention and alignment of interests between staff and shareholders. While the current holding is small relative to total voting rights, the continuation of market purchases signals a stable, structured approach to employee share ownership that may support longer-term corporate governance and engagement objectives.
The most recent analyst rating on (GB:LTHM) stock is a Hold with a £1171.00 price target. To see the full list of analyst forecasts on James Latham stock, see the GB:LTHM Stock Forecast page.
James Latham plc has issued new 25p ordinary shares at an exercise price of 980p per share under its Share Incentive Plan Scheme to several persons discharging managerial responsibilities, including Chairman Nick Latham, Finance Director David Dunmow and Executive Directors Piers Latham and Andrew Wright. The allocations marginally increase these executives’ individual shareholdings, with the chairman and an executive director now each holding just over 3% of the company, reinforcing equity-based alignment between senior management and shareholders but without materially altering the overall ownership structure.
The most recent analyst rating on (GB:LTHM) stock is a Hold with a £1076.00 price target. To see the full list of analyst forecasts on James Latham stock, see the GB:LTHM Stock Forecast page.
James Latham plc has repurchased 166,615 of its £1 preference shares at a price of £1.30 per share, with the repurchased shares to be held in treasury. Following this transaction, the company has 423,863 preference shares in issue excluding those held in treasury, a move that modestly reshapes its capital structure and may signal management’s ongoing attention to balance sheet optimisation and shareholder capital management.
The most recent analyst rating on (GB:LTHM) stock is a Hold with a £1076.00 price target. To see the full list of analyst forecasts on James Latham stock, see the GB:LTHM Stock Forecast page.
James Latham plc has issued 486 ordinary shares under its Company Share Option Plan (CSOP) to Managing Director Andrew Wright at a price of 925 pence per share, increasing his holding to 31,690 ordinary shares, equivalent to 0.16% of the company’s total voting rights. The transaction, conducted outside a trading venue, forms part of the company’s established executive incentive arrangements and marginally raises insider equity ownership, aligning senior management interests more closely with those of shareholders without materially altering the overall capital structure.
The most recent analyst rating on (GB:LTHM) stock is a Hold with a £1002.00 price target. To see the full list of analyst forecasts on James Latham stock, see the GB:LTHM Stock Forecast page.
James Latham plc has granted new share options under its Company Share Option Plan to five senior executives, including the chairman, finance director and managing director, over ordinary shares at an exercise price of 980p, exercisable between December 2030 and December 2035. Separately, the CSOP trustees have issued 999 ordinary shares at 925p to three PDMRs, marginally increasing their direct shareholdings, with the chairman and an executive director each now holding just over 3% of the company’s equity, underscoring continued alignment of senior management incentives with shareholder interests.
The most recent analyst rating on (GB:LTHM) stock is a Hold with a £1002.00 price target. To see the full list of analyst forecasts on James Latham stock, see the GB:LTHM Stock Forecast page.